Introduction to the Volume The Case for Integrating Cognitive Behavioral Therapy for Emotional Disorders and Substance Use Disorders -- Cognitive Behavioral Therapy for Social Anxiety Disorder and Alcohol Use Disorder -- Cognitive Behavioral Therapy for Comorbid Cannabis Use Disorder and Emotional Disorders -- Treating Comorbid Major Depressive Disorder and Substance Use Disorder -- Treating Comorbid Posttraumatic Stress Disorder and Substance Use Disorder -- Affect Management Training for Substance Use Disorders A Transdiagnostic Approach to Treating Co-Occurring Emotional Disorder Symptoms and Substance Use -- Smoking Cessation and Anxiety Sensitivity -- Third Wave Behavioral Treatment for Comorbid Substance Use Disorder and Emotional Disorder -- Cognitive Behavioral Therapy for Co-Occurring Anxiety and Opioid Use Disorder in People with Chronic Pain -- Cognitive Behavioral Therapy Targeted to the Successful Discontinuation of Benzodiazepine Medication.

This book focuses on effective approaches to managing the challenging problem of co-morbidity of substance abuse with other disorders. Delivering cutting edge clinical research and data-driven treatment guidelines, this volume offers an integrative approach to treatment that targets both of the co-existing problems. Can mitigate the risk of relapse, and decrease symptom severity. This fully integrated approach provides a firm grounding for clinicians and researchers alike. “This volume assembles the most expert of clinician-scientists who have dedicated their professional careers to developing, delivering, evaluating, and disseminating integrated CBT for co-occurring emotional and substance use disorders…It is enthusiastically recommended for clinician education and training programs, researchers, and also frontline CBT therapists seeking to provide the best care possible to their complex patients.” - Mark McGovern, Professor, Department of Psychiatry, Department of Medicine, Stanford University School of Medicine “Emotional disorders rarely occur in isolation, but most existing treatment protocols do not account for this. Comorbid substance use problems severely impact interventions that are ordinarily effective for anxiety and mood conditions. Dr. Wolitzky-Taylor tackles this problem head-on in this important book. Leading clinicians and scientists have provided clear and incisive recommendations that will inform beginning-level clinicians as well as experienced mental health professionals.” - N.B. Schmidt, Distinguished Research Professor and Chair, Department of Psychology, Florida State University; Director, Anxiety and Behavioral Health Clinic “a groundbreaking volume that illuminates a vital shift in mental health care, confronting head on the historical divide between the separate treatment of emotional disorders and substance abuse. Offering a comprehensive, research-based roadmap for an integrated care model, this book challenges outdated treatment paradigms, advocating for simultaneous interventions. With contributions by leading experts, this volume is a timely resource, bridging the gap between research and practice, and empowering clinicians with practical strategies for addressing complex co-morbidity problems. It is essential reading for anyone committed to the highest quality of care.” - Jasper Smits, Ph.D., Professor, Department of Psychology, University of Texas at Austin .